Factors related to changes in cardiometabolic risk
MDT intervention was associated with a higher reduction of adiposity (by
weight and BMI) and BP. Compared to the PCP group, MDT intervention, on
average (β, 95% CI), was associated to higher reductions of weight
(-4.29 Kg, -7.62, -0.97), BMI (-1.43 Kg/m2, -2.68,
-0.18), SBP (-2.18 mmHg, -4.09, -0.26), and DBP (-1.97 mmHg, -3.34,
-0.60) (Table 3). Binary analysis shows that those co-managed by MDT had
77% higher odds for reducing 5% or more of the initial weight, 83%
higher odds of reducing 1 kg/m2 of BMI, and 59%
higher odds of reducing ≥ 2 mmHg DBP compared to the PCP group (Table
4). On average, age was associated (β, 95% CI) with greater reductions
in weight (-0.09 Kg, -0.15, -0.03), BMI (-0.03 Kg/m2,
-0.06, -0.01), and no reduction in SBP (+0.07 mmHg, 0.01, 0.13) while
male gender associated to a higher increase in SBP (3.46 mmHg, 1.61,
5.31) and 42% lower odds of reducing ≥ 2 mmHg than women. Hispanic had
a higher reduction in SBP (-2.49 mmHg, -4.09, -0.26) compared to AA.
Following the intervention, higher baseline values of weight (only in
the continuous outcome analysis), BMI, SBP, DBP, and A1C were associated
with a greater reduction of each variable in both continuous and binary
outcome analyses.